yup. Article in AFR a day ago said M&G selling as is risk averse and thinks it's made enough profit now.. My reading of the FDR caution is that they will simply be looking for answers to those questions about the trial parameters and evidence of enhancement by this drug. Management has already stated they have the answers. I trust management to have done its homework and have the necessary response. The FDR questions are not unexpected; they are run of the mill questions all such trials have to answer.
The herd will run in the opposite direction tomorrow when Management has a chance to provide those answers. It would've expected and prepared those answers all along.
Ann: Change in substantial holding - Amendment, page-26
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |